Mn(II)-containing coordination nanoparticles as highly efficient T(1) contrast agents for magnetic resonance imaging

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Imaging

Background:

• Prussian blue analogue nanoparticles are a class of coordination compounds with tunable properties.
• Contrast agents are crucial for enhancing the visibility of internal body structures in medical imaging.
• Developing novel contrast agents with improved performance is an ongoing research area.

Purpose of the Study:

• To investigate the magnetic properties and potential of Mn(II)-containing Prussian blue analogue nanoparticles as contrast agents.
• To evaluate the relaxivity and contrast enhancement capabilities of these nanoparticles at high magnetic field strengths.
• To understand the relationship between nanoparticle structure and their performance as contrast agents.

Main Methods:

• Synthesis and characterization of Mn(II)-containing Prussian blue analogue nanoparticles.
• Measurement of longitudinal relaxivity (r1) at high magnetic field (7 T).
• Evaluation of positive contrast enhancement in phantom or biological samples.

Main Results:

• Observed large longitudinal relaxivities in Mn(II)-containing Prussian blue analogue nanoparticles.
• Demonstrated remarkable positive contrast enhancement at low concentrations and high field (7 T).
• Exceeded the performance of existing clinical contrast agents.

Conclusions:

• Mn(II)-containing Prussian blue analogue nanoparticles exhibit significant potential as advanced contrast agents.
• The large proportion of surface atoms in these coordination nanoparticles contributes to their superior relaxivity.
• These findings open new avenues for developing next-generation MRI contrast agents.